Intranigral Transplantation of Epigenetically Induced BDNF-Secreting Human Mesenchymal Stem Cells: Implications for Cell-Based Therapies in Parkinson's Disease

Biology of Blood and Marrow Transplantation

Volumn 16, Issue 11, 2010, Pages 1530-1540

  Somoza, Rodrigo ^a   Juri, Carlos ^b   Baes, Mauricio ^c   Wyneken, Ursula ^c   Rubio, Francisco Javier ^a,c  

^a UNIVERSIDAD DEL DESARROLLO   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c UNIVERSIDAD DE LOS ANDES   (Chile)

Author keywords

Mesenchymal stem cell transplantation; Neurotrophins; Substantia nigra; Trk receptors; Unilateral 6 hydroxydopamine lesion

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; AMPHETAMINE; BASIC FIBROBLAST GROWTH FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; EPIDERMAL GROWTH FACTOR; NESTIN; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE; TYROSINE KINASE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; CELL CULTURE; CELL THERAPY; CLINICAL FEATURE; CONTROLLED STUDY; CULTURE MEDIUM; DOPAMINERGIC SYSTEM; EPIGENETICS; GENE EXPRESSION; HISTOPATHOLOGY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOTOR DYSFUNCTION; NONHUMAN; PARKINSON DISEASE; PHENOTYPE; RAT; SUBSTANTIA NIGRA;

ACTINS; ANIMALS; BRAIN INJURIES; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CULTURE MEDIA; CULTURE MEDIA, SERUM-FREE; EPIDERMAL GROWTH FACTOR; EPIGENESIS, GENETIC; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; HUMANS; INTERMEDIATE FILAMENT PROTEINS; LOCOMOTION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; METHAMPHETAMINE; NERVE TISSUE PROTEINS; NEURONS; OXIDOPAMINE; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, TRKB; ROTATION; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 77957751719     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.06.006     Document Type: Article

References (67)

1. Azizi S.A., Stokes D., Augelli B.J., DiGirolamo C., Prockop D.J. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats-similarities to astrocyte grafts. Proc Natl Acad Sci USA 1998, 95:3908-3913.
2. Kopen G.C., Prockop D.J., Phinney D.G. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci USA 1999, 96:10711-10716.
3. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
4. Sanchez-Ramos J., Song S., Cardozo-Pelaez F., et al. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 2000, 164:247-256.
5. Woodbury D., Schwarz E.J., Prockop D.J., Black I.B. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 2000, 61:364-370.
6. Wagers A.J., Weissman I.L. Plasticity of adult stem cells. Cell 2004, 116:639-648.
7. Horwitz E.M., Le Blanc K., Dominici M., et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005, 7:393-395.
8. Iihoshi S., Honmou O., Houkin K., Hashi K., Kocsis J.D. A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats. Brain Res 2004, 1007:1-9.
9. Torrente Y., Polli E. Mesenchymal stem cell transplantation for neurodegenerative diseases. Cell Transplant 2008, 17:1103-1113.
10. Crigler L., Robey R.C., Asawachaicharn A., Gaupp D., Phinney D.G. Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol 2006, 198:54-64.
11. Sadan O., Bahat-Stromza M., Barhum Y., et al. Protective effects of neurotrophic factors-secreting cells in a 6-OHDA rat model of Parkinson disease. Stem Cells Dev 2009, 18.
12. Shen L.H., Li Y., Chen J., et al. Intracarotid transplantation of bone marrow stromal cells increases axon-myelin remodeling after stroke. Neuroscience 2006, 137:393-399.
13. Sasaki M., Radtke C., Tan A.M., et al. BDNF-hypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury. J Neurosci 2009, 29:14932-14941.
14. Li Y., Chen J., Chen X.G., et al. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 2002, 59:514-523.
15. Pisati F., Bossolasco P., Meregalli M., et al. Induction of neurotrophin expression via human adult mesenchymal stem cells: implication for cell therapy in neurodegenerative diseases. Cell Transplant 2007, 16:41-55.
16. Kim Y.J., Park H.J., Lee G., et al. Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action. Glia 2009, 57:13-23.
17. Li Y., Chen J., Wang L., Zhang L., Lu M., Chopp M. Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Neurosci Lett 2001, 316:67-70.
18. Levy Y.S., Bhat-Stroomza M., Barzilay R., et al. Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease. Cytotherapy 2008, 10:340-352.
19. Bouchez G., Sensebé L., Vourc'h P., et al. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease. Neurochem Int 2008, 52:1332-1342.
20. Arnhold S., Klein H., Klinz F.-J., et al. Human bone marrow stroma cells display certain neural characteristics and integrate in the subventricular compartment after injection into the liquor system. Eur J Cell Biol 2006, 85:551-565.
21. Fearnley J.M., Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991, 114(Pt 5):2283-2301.
22. Mogi M., Togari A., Kondo T., et al. Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease. Neurosci Lett 1999, 270:45-48.
23. Parain K., Murer M.G., Yan Q., et al. Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra. Neuroreport 1999, 10:557-561.
24. Nagatsu T., Mogi M., Ichinose H., Togari A. Changes in cytokines and neurotrophins in Parkinson's disease. J Neural Transm Suppl 2000, 277-290.
25. Hyman C., Hofer M., Barde Y.-A., et al. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 1991, 350:230-232.
26. Seroogy K.B., Lundgren K.H., Tran T.M.D., Guthrie K.M., Isackson P.J., Gail C.M. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs. J Comp Neurol 1994, 342:321-334.
27. Yan Q., Radeke M.J., Matheson C.R., Talvenheimo J., Welcher A.A., Feinstein F.C. Immunocytochemical localization of TrkB in the central nervous system of the adult rat. J Comp Neurol 1997, 378:135-157.
28. Hagg T. Neurotrophins prevent death and differentially affect tyrosine hydroxylase of adult rat nigrostriatal neurons in vivo. Exp Neurol 1998, 149:183-192.
29. Porritt M.J., Batchelor P.E., Howells D.W. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons. Exp Neurol 2005, 192:226-234.
30. Dunnett S.B., Bjorklund A. Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature 1999, 399(Suppl):A32-A39.
31. Li N., Yang H., Lu L., Duan C., Zhoa C., Zhao H. Spontaneous expression of neural phenotype and NGF, TrkA, TrkB genes in marrow stromal cells. Biochem Biophys Res Commun 2007, 356:561-568.
32. Wilkins A., Kemp K., Ginty M., Hares K., Malfam E., Scolding N. Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro. Stem Cell Res 2009, 3:63-70.
33. Chen X., Katakowski M., Li Y., et al. Human bone marrow stromal cell cultures conditioned by traumatic brain tissue extracts: growth factor production. J Neurosci Res 2002, 69:687-691.
34. Somoza R., Conget P., Rubio F.J. Neuropotency of human mesenchymal stem cell cultures: clonal studies reveal the contribution of cell plasticity and cell contamination. Biol Blood Marrow Transplant 2008, 14:546-555.
35. Nomura T., Honmou O., Harada K., Houkin K., Hamada H., Kocsis J.D. I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Neuroscience 2005, 136:161-169.
36. Iwanami A., Kaneko S., Nakamura M., et al. Transplantation of human neural stem cells for spinal cord injury in primates. J Neurosci Res 2005, 80:182-190.
37. Ronsyn M.W., Daans J., Spaepen G., et al. Plasmid-based genetic modification of human bone marrow-derived stromal cells: analysis of cell survival and transgene expression after transplantation in rat spinal cord. BMC Biotechnol 2007, 7:90.
38. Phinney D.G., Kopen G., Righter W., Webster S., Tremain N., Prockop D.J. Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J Cell Biochem 1999, 75:424-436.
39. Freshney R.I. Culture of Animal Cells: A Manual of Basic Techniques 2000, Wiley-Liss, Glasgow, UK. 4th ed.
40. Rubio F.J., Bueno C., Villa A., Navarro B., Martínez-Serrano A. Genetically perpetuated human neural stem cells engraft and differentiate into the adult mammalian brain. Mol Cell Neurosci 2000, 16:1-13.
41. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Academic Press, San Diego, CA. 4th ed.
42. Burke R.E., Cadet J.L., Kent J.D., Karanas A.L., Jackson-Lewis V. An assessment of the validity of densitometric measures of striatal tyrosine hydroxylase-positive fibers: relationship to apomorphine-induced rotations in 6-hydroxydopamine lesioned rats. J Neurosci Methods 1990, 35:63-73.
43. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1997, Academic Press, San Diego, CA. 3rd ed.
44. Conget P.A., Minguell J.J. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 1999, 181:67-73.
45. Liu Z., Martin L.J. Olfactory bulb core is a rich source of neural progenitor and stem cells in adult rodent and human. J Comp Neurol 2003, 459:368-391.
46. Muraglia A., Cancedda R., Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 2000, 113(Pt 7):1161-1166.
47. Zhang X., Klueber K.M., Guo Z., Lu C., Roisen F.J. Adult human olfactory neural progenitors cultured in defined medium. Exp Neurol 2004, 186:112-123.
48. Poser S., Impey S., Xia Z., Storm D.R. Brain-derived neurotrophic factor protection of cortical neurons from serum withdrawal-induced apoptosis is inhibited by cAMP. J Neurosci 2003, 23:4420-4427.
49. Chun H.S., Son J.J., Son J.H. Identification of potential compounds promoting BDNF production in nigral dopaminergic neurons: clinical implication in Parkinson's disease. Neuroreport 2000, 11:511-514.
50. Peltier J., O'Neill A., Schaffer D.V. PI3K/Akt and CREB regulate adult neural hippocampal progenitor proliferation and differentiation. Dev Neurobiol 2007, 67:1348-1361.
51. Martinez-Serrano A., Rubio F.J., Navarro B., Bueno C., Villa A. Human neural stem and progenitor cells: in vitro and in vivo properties, and potential for gene therapy and cell replacement in the CNS. Curr Gene Ther 2001, 1:279-299.
52. Vogel W., Grunebach F., Messam C.A., Kanz L., Brugger W., Buhring H- J. Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cells. Haematologica 2003, 88:126-133.
53. Tondreau T., Lagneaux L., Dejeneffe M., et al. Bone marrow-derived mesenchymal stem cells already express specific neural proteins before any differentiation. Differentiation 2004, 72:319-326.
54. Minguell J.J., Fierro F.A., Epuñan M.J., Erices A.A., Sierralta W.D. Nonstimulated human uncommitted mesenchymal stem cells express cell markers of mesenchymal and neural lineages. Stem Cells Dev 2005, 14:408-414.
55. Choong P.F., Mok P.L., Cheong S.K., Leong C.F., Then K.Y. Generating neuron-like cells from BM-derived mesenchymal stromal cells in vitro. Cytotherapy 2007, 9:170-183.
56. Kan I., Ben Zur T., Barthum Y., et al. Dopaminergic differentiation of human mesenchymal stem cells-utilization of bioassay for tyrosine hydroxylase expression. Neurosci Lett 2007, 419:28-33.
57. Bibel M., Barde Y.A. Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev 2000, 14:2919-2937.
58. Chao M.V. Dependence receptors: what is the mechanism?. Sci STKE 2003, 2003:PE38.
59. Baquet Z.C., Bickford P.C., Jones K.R. Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta. J Neurosci 2005, 25:6251-6259.
60. Cellerino A., Pinzón-Duarte G., Carroll P., Kohler K. Brain-derived neurotrophic factor modulates the development of the dopaminergic network in the rodent retina. J Neurosci 1998, 18:3351-3362.
61. Akerud P., Alberch J., Eketjäll S., Wagner J., Arenas E. Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons. J Neurochem 1999, 73:70-78.
62. Bustos G., Abarca J., Bustos V., et al. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease. J Neurosci Res 2009, 87:2308-2318.
63. Blochl A., Sirrenberg C. Neurotrophins stimulate the release of dopamine from rat mesencephalic neurons via Trk and p75Lntr receptors. J Biol Chem 1996, 271:21100-21107.
64. Blandini F., Levandis G., Bazzini E., Nappi G., Armentero M.T. Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model. Eur J Neurosci 2007, 25:397-405.
65. Ourednik J., Ourednik V., Lynch W.P., Schachner M., Snyder E.Y. Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat Biotechnol 2002, 20:1103-1110.
66. Rubio F.J., Kokaia Z., Arco A., et al. BDNF gene transfer to the mammalian brain using CNS-derived neural precursors. Gene Ther 1999, 6:1851-1866.
67. Valle-Prieto A, Conget PA. Human mesenchymal stem cells efficiently manage oxidative stress. Stem Cells Dev. [Epub ahead of print].